Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 25-Apr-2022 titled Alembic Pharmaceuticals announces its wholly owned subsidiary, Aleor Dermaceuticals Limited receives USFDA Final Approval for Clobetasol Propionate Foam, 0.05%